Srf1 is a novel regulator of phospholipase D activity and is essential to buffer the toxic effects of C16:0 platelet activating factor

PLoS Genetics

Volumn 7, Issue 2, 2011, Pages

  Kennedy, Michael A ^a   Kabbani, Nazir ^a   Lambert, Jean Philippe ^a   Swayne, Leigh Anne ^a   Ahmed, Fida ^a   Figeys, Daniel ^a   Bennett, Steffany A L ^a   Bryan, Jennnifer ^b   Baetz, Kristin ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GREEN FLUORESCENT PROTEIN; MUTANT PROTEIN; PHOSPHATIDIC ACID; PHOSPHATIDYLCHOLINE; PHOSPHOLIPASE D; PROTEIN SPO14; REGULATOR PROTEIN; SPO14 REGULATORY FACTOR 1 PROTEIN; THROMBOCYTE ACTIVATING FACTOR; UNCLASSIFIED DRUG; 1 HEXADECYL 2 ACETYL GLYCERO 3 PHOSPHOCHOLINE; 1 O HEXADECYLGLYCEROPHOSPHOCHOLINE; 1-HEXADECYL-2-ACETYL-GLYCERO-3-PHOSPHOCHOLINE; 1-O-HEXADECYLGLYCEROPHOSPHOCHOLINE; DRUG DERIVATIVE; GLYCEROPHOSPHOLIPID; SACCHAROMYCES CEREVISIAE PROTEIN; SRF1 PROTEIN, S CEREVISIAE;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; CATALYSIS; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME REGULATION; GENE; GENE DELETION; HYDROLYSIS; MAMMAL CELL; MITOSIS; MOUSE; NERVE CELL; NONHUMAN; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SACCHAROMYCES CEREVISIAE; SPO14 REGULATORY FACTOR 1 GENE; YDL133W GENE; YEAST CELL; CELL LINE; DRUG EFFECT; GENETICS; HUMAN; LIPID METABOLISM; METABOLISM; MUTATION; PHYSIOLOGY;

MAMMALIA; SACCHAROMYCES CEREVISIAE;

ALZHEIMER DISEASE; CELL LINE; GLYCEROPHOSPHOLIPIDS; HUMANS; LIPID METABOLISM; MUTATION; NEURONS; PHOSPHOLIPASE D; PLATELET ACTIVATING FACTOR; SACCHAROMYCES CEREVISIAE; SACCHAROMYCES CEREVISIAE PROTEINS;

EID: 79952263955     PISSN: 15537390     EISSN: 15537404     Source Type: Journal    
DOI: 10.1371/journal.pgen.1001299     Document Type: Article

References (54)

1. Ryan SD, Whitehead SN, Swayne LA, Moffat TC, Hou W, et al. (2009) Amyloid-{beta}42 signals tau hyperphosphorylation and compromises neuronal viability by disrupting alkylacylglycerophosphocholine metabolism. Proc Natl Acad Sci U S A 106: 20936-20941.
2. Sanchez-Mejia RO, Newman JW, Toh S, Yu GQ, Zhou Y, et al. (2008) Phospholipase A2 reduction ameliorates cognitive deficits in a mouse model of Alzheimer's disease. Nat Neurosci 11: 1311-1318.
3. Klein J, (2000) Membrane breakdown in acute and chronic neurodegeneration: focus on choline-containing phospholipids. J Neural Transm 107: 1027-1063.
4. Sweet RA, Panchalingam K, Pettegrew JW, McClure RJ, Hamilton RL, et al. (2002) Psychosis in Alzheimer disease: postmortem magnetic resonance spectroscopy evidence of excess neuronal and membrane phospholipid pathology. Neurobiol Aging 23: 547-553.
5. Kriem B, Sponne I, Fifre A, Malaplate-Armand C, Lozac'h-Pillot K, et al. (2005) Cytosolic phospholipase A2 mediates neuronal apoptosis induced by soluble oligomers of the amyloid-beta peptide. FASEB J 19: 85-87.
6. Kita Y, Ohto T, Uozumi N, Shimizu T, (2006) Biochemical properties and pathophysiological roles of cytosolic phospholipase A2s. Biochim Biophys Acta 1761: 1317-1322.
7. Calon F, Lim GP, Yang F, Morihara T, Teter B, et al. (2004) Docosahexaenoic acid protects from dendritic pathology in an Alzheimer's disease mouse model. Neuron 43: 633-645.
8. Bate C, Tayebi M, Williams A, (2010) Phospholipase A2 inhibitors protect against prion and Abeta mediated synapse degeneration. Mol Neurodegener 5: 13.
9. Li J, Hu J, Shao B, Zhou W, Cui Y, et al. (2009) Protection of PMS777, a new AChE inhibitor with PAF antagonism, against amyloid-beta-induced neuronal apoptosis and neuroinflammation. Cell Mol Neurobiol 29: 589-595.
10. Ryan SD, Harris CS, Mo F, Lee H, Hou ST, et al. (2007) Platelet activating factor-induced neuronal apoptosis is initiated independently of its G-protein coupled PAF receptor and is inhibited by the benzoate orsellinic acid. J Neurochem 103: 88-97.
11. Hoon S, St Onge RP, Giaever G, Nislow C, (2008) Yeast chemical genomics and drug discovery: an update. Trends Pharmacol Sci 29: 499-504.
12. Khurana V, Lindquist S, (2010) Modelling neurodegeneration in Saccharomyces cerevisiae: why cook with baker's yeast? Nat Rev Neurosci 11: 436-449.
13. Nielsen J, (2009) Systems biology of lipid metabolism: from yeast to human. FEBS Lett 583: 3905-3913.
14. Nakayama R, Kumagai H, Saito K, (1994) Evidence for production of platelet-activating factor by yeast Saccharomyces cerevisiae cells. Biochim Biophys Acta 1199: 137-142.
15. Nakayama R, Udagawa H, Kumagai H, (1997) Changes in PAF (platelet-activating factor) production during cell cycle of yeast Saccharomyces cerevisiae. Biosci Biotechnol Biochem 61: 631-635.
16. Nakayama R, Yun C, Tamaki H, Saito K, Kumagai H, (1996) Physiological action of PAF in yeast Saccharomyces cerevisiae. Adv Exp Med Biol 416: 45-50.
17. Zaremberg V, McMaster CR, (2002) Differential partitioning of lipids metabolized by separate yeast glycerol-3-phosphate acyltransferases reveals that phospholipase D generation of phosphatidic acid mediates sensitivity to choline-containing lysolipids and drugs. J Biol Chem 277: 39035-39044.
18. Zaremberg V, Gajate C, Cacharro LM, Mollinedo F, McMaster CR, (2005) Cytotoxicity of an anti-cancer lysophospholipid through selective modification of lipid raft composition. J Biol Chem 280: 38047-38058.
19. Brewer C, Bonin F, Bullock P, Nault MC, Morin J, et al. (2002) Platelet activating factor-induced apoptosis is inhibited by ectopic expression of the platelet activating factor G-protein coupled receptor. J Neurochem 82: 1502-1511.
20. Gavin AC, Aloy P, Grandi P, Krause R, Boesche M, et al. (2006) Proteome survey reveals modularity of the yeast cell machinery. Nature 440: 631-636.
21. Krogan NJ, Cagney G, Yu H, Zhong G, Guo X, et al. (2006) Global landscape of protein complexes in the yeast Saccharomyces cerevisiae. Nature 440: 637-643.
22. Lambert JP, Mitchell L, Rudner A, Baetz K, Figeys D, (2009) A novel proteomics approach for the discovery of chromatin-associated protein networks. Mol Cell Proteomics 8: 870-882.
23. Lambert JP, Baetz K, Figeys D, (2010) Of proteins and DNA-proteomic role in the field of chromatin research. Mol Biosyst 6: 30-37.
24. Rudge SA, Morris AJ, Engebrecht J, (1998) Relocalization of phospholipase D activity mediates membrane formation during meiosis. J Cell Biol 140: 81-90.
25. Honigberg SM, Conicella C, Espositio RE, (1992) Commitment to meiosis in Saccharomyces cerevisiae: involvement of the SPO14 gene. Genetics 130: 703-716.
26. Connolly JE, Engebrecht J, (2006) The Arf-GTPase-activating protein Gcs1p is essential for sporulation and regulates the phospholipase D Spo14p. Eukaryot Cell 5: 112-124.
27. Marston AL, Tham WH, Shah H, Amon A, (2004) A genome-wide screen identifies genes required for centromeric cohesion. Science 303: 1367-1370.
28. Ella KM, Dolan JW, Meier KE, (1995) Characterization of a regulated form of phospholipase D in the yeast Saccharomyces cerevisiae. Biochem J 307: 799-805.
29. Ella KM, Meier GP, Bradshaw CD, Huffman KM, Spivey EC, et al. (1994) A fluorescent assay for agonist-activated phospholipase D in mammalian cell extracts. Anal Biochem 218: 136-142.
30. Riedel CG, Mazza M, Maier P, Korner R, Knop M, (2005) Differential requirement for phospholipase D/Spo14 and its novel interactor Sma1 for regulation of exocytotic vesicle fusion in yeast meiosis. J Biol Chem 280: 37846-37852.
31. Loewen CJ, Gaspar ML, Jesch SA, Delon C, Ktistakis NT, et al. (2004) Phospholipid metabolism regulated by a transcription factor sensing phosphatidic acid. Science 304: 1644-1647.
32. Cai D, Netzer WJ, Zhong M, Lin Y, Du G, et al. (2006) Presenilin-1 uses phospholipase D1 as a negative regulator of beta-amyloid formation. Proc Natl Acad Sci U S A 103: 1941-1946.
33. Cai D, Zhong M, Wang R, Netzer WJ, Shields D, et al. (2006) Phospholipase D1 corrects impaired betaAPP trafficking and neurite outgrowth in familial Alzheimer's disease-linked presenilin-1 mutant neurons. Proc Natl Acad Sci U S A 103: 1936-1940.
34. Scott SA, Selvy PE, Buck JR, Cho HP, Criswell TL, et al. (2009) Design of isoform-selective phospholipase D inhibitors that modulate cancer cell invasiveness. Nat Chem Biol 5: 108-117.
35. Ryan SD, Harris CS, Carswell CL, Baenziger JE, Bennett SA, (2008) Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons. J Lipid Res 49: 2250-2258.
36. Fairn GD, Curwin AJ, Stefan CJ, McMaster CR, (2007) The oxysterol binding protein Kes1p regulates Golgi apparatus phosphatidylinositol-4-phosphate function. Proc Natl Acad Sci U S A 104: 15352-15357.
37. Rose K, Rudge SA, Frohman MA, Morris AJ, Engebrecht J, (1995) Phospholipase D signaling is essential for meiosis. Proc Natl Acad Sci U S A 92: 12151-12155.
38. Rudge SA, Cavenagh MM, Kamath R, Sciorra VA, Morris AJ, et al. (1998) ADP-Ribosylation factors do not activate yeast phospholipase Ds but are required for sporulation. Mol Biol Cell 9: 2025-2036.
39. Mendonsa R, Engebrecht J, (2009) Phospholipase D function in Saccharomyces cerevisiae. Biochim Biophys Acta 1791: 970-974.
40. Pai JK, Siegel MI, Egan RW, Billah MM, (1988) Phospholipase D catalyzes phospholipid metabolism in chemotactic peptide-stimulated HL-60 granulocytes. J Biol Chem 263: 12472-12477.
41. Kihara Y, Ishii S, Kita Y, Toda A, Shimada A, et al. (2005) Dual phase regulation of experimental allergic encephalomyelitis by platelet-activating factor. J Exp Med 202: 853-863.
42. Walther TC, Brickner JH, Aguilar PS, Bernales S, Pantoja C, et al. (2006) Eisosomes mark static sites of endocytosis. Nature 439: 998-1003.
43. Aguilar PS, Frohlich F, Rehman M, Shales M, Ulitsky I, et al. (2010) A plasma-membrane E-MAP reveals links of the eisosome with sphingolipid metabolism and endosomal trafficking. Nat Struct Mol Biol.
44. Oliveira TG, Di Paolo G, (2010) Phospholipase D in brain function and Alzheimer's disease. Biochim Biophys Acta 1801: 799-805.
45. Longtine MS, McKenzie A 3rd, Demarini DJ, Shah NG, Wach A, et al. (1998) Additional modules for versatile and economical PCR-based gene deletion and modification in Saccharomyces cerevisiae. Yeast 14: 953-961.
46. Rigaut G, Shevchenko A, Rutz B, Wilm M, Mann M, et al. (1999) A generic protein purification method for protein complex characterization and proteome exploration. Nat Biotechnol 17: 1030-1032.
47. Abelson JN, Simon ML, Gutherie C, Fink GR, (2004) Guide to Yeast Genetics and Molecular Biology. California Elsevier Academic Press.
48. Memarian N, Jessulat M, Alirezaie J, Mir-Rashed N, Xu J, et al. (2007) Colony size measurement of the yeast gene deletion strains for functional genomics. BMC Bioinformatics 8: 117.
49. Parsons AB, Brost RL, Ding H, Li Z, Zhang C, et al. (2004) Integration of chemical-genetic and genetic interaction data links bioactive compounds to cellular target pathways. Nat Biotechnol 22: 62-69.
50. Parsons AB, Lopez A, Givoni IE, Williams DE, Gray CA, et al. (2006) Exploring the mode-of-action of bioactive compounds by chemical-genetic profiling in yeast. Cell 126: 611-625.
51. Pinheiro JC, Bates DM, (2000) Mixed-Effects Models in S and S-Plus; Chambers J, editor. New York Springer.
52. Pinheiro JC, Bates DM, DebRoy S, Sarkar D, (2008) nlme: Linear and Nonlinear Mixed Effects Models. R package 3.1-90 ed ed.
53. Team RDC (2008) R: A Language and Environment for Statistical Computing. Vienna, Austria R Foundation for Statistical Computing.
54. Sikorski RS, Hieter P, (1989) A system of shuttle vectors and yeast host strains designed for efficient manipulation of DNA in Saccharomyces cerevisiae. Genetics 122: 19-27.